Cell-free synthesis of opiate binding sites

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Opiate receptors are crucial targets for pain management and neurological research.
• Understanding the synthesis of these receptors at the molecular level is essential for drug development.

Purpose of the Study:

• To establish a method for detecting and quantifying opiate binding sites synthesized during in vitro translation.
• To investigate the expression of opiate binding sites in various neuronal and glial cell lines.

Main Methods:

• Isolation of polyadenylated [poly(A)(+)] RNA from different cell lines (NG 108-15 hybridoma, C6BU1 glioma, N18TG2, NB2aAg, NB41A3 neuroblastoma).
• In vitro translation of RNA using a rabbit reticulocyte lysate system.
• Assay of translation products for binding to [(3)H]bremazocine, a known opiate ligand.
• Separation of bound and free ligands via column chromatography.

Main Results:

• Stereospecific and saturable binding of [(3)H]bremazocine was demonstrated with RNA from NG 108-15 cells (Kd = 2.4 ± 1.0 nM).
• NG 108-15 cells synthesized opiate binding sites at a rate of 6.2 ± 0.5 fmol per μg of poly(A)(+) RNA.
• N18TG2 neuroblastoma cells synthesized five times fewer opiate binding sites compared to NG 108-15 cells.
• No detectable opiate binding was observed with RNA from C6BU1 glioma, NB2aAg, or NB41A3 neuroblastoma cells.

Conclusions:

• The developed procedure effectively detects de novo synthesized opiate binding sites.
• NG 108-15 hybridoma cells are a source of mRNA encoding functional opiate binding sites.
• Differential expression of opiate binding sites exists across various neuronal and glial cell types.